Supplement dated June 22, 2022
to the pricing supplements, each dated June 17, 2022, to the
Product Prospectus Supplement No. ERN-ETF-1 Dated
March 3, 2022, the Prospectus Supplement Dated September
14, 2021 and the Prospectus, Dated September 14, 2021
(each, a “Note Prospectus”)
Filed pursuant to Rule 424(b)(3)
Registration Statement 333-259205

Royal Bank of Canada
Notes Linked to a Basket of Closed-End Funds, due June 21, 2024
Global Medium-Term Notes, Series I
CUSIPS: 78015QAX9 and 78015QAY7
(the “notes”)

This document (the “supplement”) supplements each Note Prospectus. Capitalized terms used but not defined in this supplement have the meanings set forth in each Note Prospectus.
The Initial Price for each Basket Component was determined after the close of trading on June 22, 2022, in the manner contemplated by each Note Prospectus. The Initial Price for each Basket Component is set forth in the table below:

 
Basket Component
 
Ticker
 
Initial Price
 
BlackRock Innovation and Growth Trust
 
BIGZ
 
$7.711318
 
BlackRock Enhanced Global Dividend Trust
 
BOE
 
$9.765971
 
BlackRock Science and Technology Trust II
 
BSTZ
 
$20.263
 
BlackRock Enhanced Capital and Income Fund, Inc.
 
CII
 
$17.16672
 
Calamos Strategic Total Return Fund
 
CSQ
 
$13.00721
 
BlackRock Debt Strategies Fund, Inc.
 
DSU
 
$9.027904
 
Eaton Vance Enhanced Equity Income Fund
 
EOI
 
$14.56798
 
The Gabelli Dividend & Income Trust
 
GDV
 
$19.92237
 
Western Asset High Income Opportunity Fund Inc.
 
HIO
 
$3.84234
 
PGIM High Yield Bond Fund, Inc.
 
ISD
 
$12.1013
 
Nuveen Core Equity Alpha Fund
 
JCE
 
$12.81114
 
Nuveen Credit Strategies Income Fund
 
JQC
 
$5.211368
 
Nuveen Real Asset Income and Growth Fund
 
JRI
 
$12.7691
 
Nuveen Floating Rate Income Opportunity Fund
 
JRO
 
$8.192545
 
Tri-Continental Corporation
 
TY
 
$25.85826


Documentation

You should read this supplement, together with the documents listed below, which together contain the terms of the notes and supersede all prior or contemporaneous oral statements as well as any other written materials. You should carefully consider, among other things, the matters set forth in the section "Selected Risk Considerations" beginning on page P-8 of the applicable Pricing Supplement, and “Additional Risk Factors Specific to the Notes” beginning on page PS-6 of product supplement ERN-ETF-1, and on page S-2 of the prospectus supplement, as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting, and other advisors before you make any invest decision relating to the notes.

You may access these documents on the SEC website at www.sec.gov as follows:

Pricing Supplement relating to CUSIP 78015QAX9, dated June 17, 2022:
https://www.sec.gov/Archives/edgar/data/1000275/000114036122023854/brhc10038925_424b2.htm
Pricing Supplement relating to CUSIP 78015QAY7, dated June 17, 2022:
https://www.sec.gov/Archives/edgar/data/1000275/000114036122023855/brhc10038926_424b2.htm
Product Prospectus Supplement ERN-ETF-1 dated March 3, 2022:
https://www.sec.gov/Archives/edgar/data/1000275/000114036122007839/brhc10034774_424b5.htm
Prospectus Supplement dated September 14, 2021:
https://www.sec.gov/Archives/edgar/data/1000275/000121465921009472/rbcsupp911210424b3.htm
Prospectus dated September 14, 2021:
https://www.sec.gov/Archives/edgar/data/1000275/000121465921009470/rbc911212424b3.htm

Our Central Index Key, or CIK, on the SEC website is 1000275. Unless otherwise indicated or unless the context requires otherwise, all references in this supplement to “we,” “us,” “our,” or similar references are to Royal Bank of Canada.